The post Shirkada Agmas East Africa appeared first on Agmas Medical.

Compared to many other countries, Germany has managed the COVID-19 crisis well, owing to its properly funded health system, technological edge, and decisive leadership. But beyond any unique feature of the German system is something that all countries can replicate: a strong commitment to building public trust.

Germany is often referred to as a positive example of how to manage the COVID-19 pandemic. We were successful in preventing the overburdening of our health system. The curve of infections is clearly flattening. And the proportion of severe cases and fatalities is lower in Germany than in many other countries. But this makes us humble, rather than overconfident.

I see three reasons why Germany is coming through this crisis relatively well, for now. First, the German health-care system was in good shape going into the crisis; everyone has had full access to medical care. This is a merit not just of the current government but of a system that was built over the course of many governments. With an excellent network of general practitioners available to deal with milder COVID-19 cases, hospitals have been able to focus on the more severely ill.

Second, Germany was not the first country to be hit by the virus, and thus had time to prepare. While we have always kept a relatively large number of hospital beds available, particularly in intensive-care units, we also took the COVID-19 threat seriously from the beginning. Accordingly, the country’s ICU capacity was increased by 12,000 beds to 40,000 very quickly.

Third, Germany is home to many laboratories that can test for the virus, and to many distinguished researchers in the field, which helps to explain why the first rapid COVID-19 test was developed here. With a population of around 83 million people, we are able to perform up to one million diagnostic tests per day, and will soon have the capacity to perform around five million antibody tests per month. Extensive testing is like pointing a flashlight in the dark: without it, you can see only shades of grey; but with it, you can see details clearly and immediately. And when it comes to a disease outbreak, you can’t control what you can’t see.

To be sure, as Germany’s federal minister of health, I recognize we are seeing only momentary snapshots. No one can predict with confidence how the pandemic will develop in a few weeks or months. We have not imposed national curfews, but we have asked citizens to stay at home voluntarily. Like many other countries, we have been living under severe restrictions on public and private life for two months. From what we know, this response has been necessary and effective.

Yet the consequences of the lockdown cannot be ignored, which is why we are gradually trying to return to normal. The challenge is that reducing protective measures is potentially as fraught an issue as introducing them in the first place. Though we are operating under conditions of deep uncertainty, we can be certain about the danger a second epidemic wave poses. Thus, we remain vigilant.https://w.soundcloud.com/player/?url=https%3A//api.soundcloud.com/tracks/825039268&color=%23ff5500&auto_play=false&hide_related=false&show_comments=true&show_user=true&show_reposts=false&show_teaser=true&visual=true

Only time will tell if we have made the right decisions, so I am careful about drawing lessons from the crisis at this point. But a few things already seem clear to me.

First, it is critical that governments inform the public not just about what they know, but also about what they do not know. That is the only way to build the trust needed to fight a lethal virus in a democratic society. No democracy can force its citizens to change their behavior – at least not without incurring high costs. In pursuing a coordinated, collective response, transparency and accurate information is far more effective than coercion.

In Germany, we have succeeded in slowing the spread of the virus because the vast majority of citizens want to cooperate, out of a sense of responsibility for themselves and others. But to maintain this success, the government must complement timely information about the virus with open public debate and a roadmap for recovery.

Second, in addition to informing the public, governments should show that they are relying on citizens to understand the situation and what it demands. Because they are informed, German citizens know that a return to normality is not possible without a vaccine. In thinking about our new, daily routines, our formula is to pursue as much normality as possible with as much protection as necessary.

As long as our decisions about where and how we loosen restrictions accord with clear and sensible criteria, we trust that German citizens will support them. Our decisions should be driven by evidence and emphasize reducing the risk of infection. We know that social distancing is the most effective protection. When people remain at least five feet (1.5 meters) apart, the risk of infection is reduced substantially. And if we can ensure compliance with basic rules of hygiene, the risk drops even further. The remaining residual risks can be handled in various ways, depending on the situation.

Third, the pandemic has shown why an interconnected world needs global-level crisis management. Sadly, multilateral cooperation has become more difficult in recent years, even among close allies. Now that we see how much we need one another, the current crisis should be a wake-up call. No single country can manage a pandemic alone. We need international coordination, and if the institutions that exist for this purpose are not functioning well enough, we must work together to improve them.

Fourth, we Europeans must reconsider how we approach globalization, recognizing that it is critical to produce necessary essential goods like medical equipment within the European Union. We will need to diversify our supply chains to avoid being wholly dependent on any one country or region. But rethinking globalization does not mean reducing international cooperation. On the contrary, joint efforts among EU member states are already driving progress toward a vaccine. Once discovered, it will be only prudent to ensure that the vaccine is produced in Europe, even as it is made available worldwide.

Like most crises, this one offers opportunities. In many areas, it has brought out the best in us: a new sense of community, a greater willingness to help others, and renewed flexibility and creativity. There can be no doubt that the medium-term consequences of the pandemic will be tough. But despite all the difficulties and uncertainties that lie ahead, I remain optimistic. In Germany and elsewhere, we are witnessing what our liberal democracies and citizens are capable of.

The post How Germany contained the coronavirus appeared first on Agmas Medical.

7 Basic Tips to Maintaining Medical Equipment

1. Ensure the Power & Grounding of the building is good before powering on any equipment.
2. Ensure the UPS is charged and its still retaining current/volts before putting the machines to full use.
3. Do not operate the machine in a humid environment.
4. Equipment should be operated in a well ventilated rom or with an operational Air conditioner in the room.
5. Equipment should not be faced directly to sunlight.
6. Do not use a damaged power cable, all cables should be properly placed in the right position.
7. All laboratory machines should be checked that they are properly grounded

• More and more industries are realizing the benefits of business automation, and manual processes are petering out. Healthcare is one such industry that is seeing a solid rise in the adoption of software solutions like equipment management software for maintaining hospital equipment.

Such systems provide complete management capabilities to hospitals, including asset tracking, equipment maintenance, vendor and staff management, and compliance regulation.

These solutions also enable biomedical engineers to design preventive maintenance routines to prevent untimely breakdowns. In addition to this, modern healthcare organizations organize audits to gain compliance and track the entire lifecycle of assets.

For more enquiries you can contact us at service@agmas.co

The post 7 General Maintenance Tips for Medical Equipment appeared first on Agmas Medical.

A possible vaccine against SARS-COV-2, the strain of coronavirus that causes COVID-19, has been shown to be at least partially effective, a Chinese study published Friday confirmed.

The study showed that a particular active substance triggered an immune response to the SARS-COV-2 virus in the human body. Further experiments are necessary to find out if the reaction would also prevent infection with the virus in the first place.

“These results represent an important milestone,” said Professor Wei Chen who was responsible for the study at the Beijing Institute of Biotechnology.

The study, published in medical journal Lancet, proved that the active substance Ad5-nCoV was safe and well-tolerated. The active substance is the biologically active ingredient of any drug or immunization.

Vaccine efforts a mix of competition and cooperation

Scientists advise “cautious” interpretation

The phase 1 trial involved the substance being administered to 108 healthy volunteers in Hubei province, the original epicenter of the outbreak.

“The Ad5 vectored COVID-19 vaccine is tolerable and immunogenic at 28 days post vaccination,” the authors of the study wrote. A final evaluation will be made after six months. A double-blind study with a control group has already been started as a phase trial.

However, Wei was quick to advise “caution” on interpreting the results too optimistically.

“A promising vision for the development of COVID-19 vaccines is emerging, but we are still a long way from a vaccine that is accessible to all,” he said. The results should be interpreted “cautiously,” he added.

The Lancet estimates that around 100 potential active substances are in development worldwide, including in the UK where a huge vaccine test of over 10,000 people will begin soon.

The post Coronavirus vaccine human tests show initial promise appeared first on Agmas Medical.